Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Diabetes Research|January 10, 2022
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental StudyAnnunziata Nusca, Federico Bernardini, Fabio Mangiacapra, et al.
The American Journal of Cardiology|March 16, 2015
Comparison among patients≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stentsFabio Mangiacapra, Elisabetta Ricottini, Giuseppe Di Gioia, et al.
Plos One|October 24, 2017
Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndromeGiuseppe Patti, Ilaria Cavallari, Emilia Antonucci, et al.
Circulation. Cardiovascular Interventions|May 6, 2015
Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach: Development and Validation of a New Bleeding Risk ScoreFabio Mangiacapra, Elisabetta Ricottini, Emanuele Barbato, et al.
Journal of Thrombosis and Thrombolysis|February 17, 2018
Impact of platelet reactivity on 5-year clinical outcomes following percutaneous coronary intervention: a landmark analysisFabio Mangiacapra, Iginio Colaiori, Elisabetta Ricottini, et al.
The American Journal of Cardiology|February 11, 2014
Impact of chronic kidney disease on platelet reactivity and outcomes of patients receiving clopidogrel and undergoing percutaneous coronary interventionFabio Mangiacapra, Ilaria Cavallari, Emanuele Barbato, et al.
Journal of Cardiovascular Translational Research|November 17, 2019
Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary InterventionFabio Mangiacapra, Edoardo Bressi, Iginio Colaiori, et al.
Journal of the American College of Cardiology|March 16, 2013
Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) studyGiuseppe Patti, Fabrizio Tomai, Rosetta Melfi, et al.
The American Journal of Cardiology|January 13, 2025
Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary InterventionAnnunziata Nusca, Maria Pia Di Bitonto, Agostino Spanò, et al.
Journal of Cardiovascular Translational Research|October 3, 2018
Impact of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio on 5-Year Clinical Outcomes of Patients with Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary InterventionEdoardo Bressi, Fabio Mangiacapra, Elisabetta Ricottini, et al.
Pageof 6